Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
Clinical trial NCT03212963 · TERMINATED
Trial details
- NCT number
- NCT03212963
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2019-08-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.